NICE News
Most Popular NICE Story
It's final: Tasigna in, Sprycel out in NICE guidelines
The National Institute for Health and Clinical Excellence has struck again. Despite two appeals of its draft recommendations, the agency let in only one new drug for chronic myeloid leukemia. Read more...
Latest Headlines
- February 6, 2012
- February 2, 2012
- January 13, 2012
- January 12, 2012
- December 14, 2011
- December 6, 2011
- December 1, 2011
- November 30, 2011
- November 10, 2011
- November 4, 2011
- November 1, 2011
- October 18, 2011
- October 14, 2011
- September 30, 2011
- September 16, 2011
- September 9, 2011
- September 6, 2011
- August 23, 2011
- August 18, 2011
- August 17, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
